These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 38862749)

  • 1. Exploring the Potential of Plant-Based Nanotechnology in Cancer Immunotherapy: Benefits, Limitations, and Future Perspectives.
    Pandey A; Karmous I
    Biol Trace Elem Res; 2024 Jun; ():. PubMed ID: 38862749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticle-based immunoengineering strategies for enhancing cancer immunotherapy.
    Dang BN; Kwon TK; Lee S; Jeong JH; Yook S
    J Control Release; 2024 Jan; 365():773-800. PubMed ID: 38081328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoengineering in glioblastoma imaging and therapy.
    Zanganeh S; Georgala P; Corbo C; Arabi L; Ho JQ; Javdani N; Sepand MR; Cruickshank K; Campesato LF; Weng CH; Hemayat S; Andreou C; Alvim R; Hutter G; Rafat M; Mahmoudi M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Nov; 11(6):e1575. PubMed ID: 31407522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining Nanomedicine and Immunotherapy.
    Shi Y; Lammers T
    Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of cancer-immunity cycle and tumor microenvironment by nanobiomaterials to enhance tumor immunotherapy.
    Yang J; Zhang C
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jul; 12(4):e1612. PubMed ID: 32114718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnology synergized immunoengineering for cancer.
    Chauhan DS; Dhasmana A; Laskar P; Prasad R; Jain NK; Srivastava R; Jaggi M; Chauhan SC; Yallapu MM
    Eur J Pharm Biopharm; 2021 Jun; 163():72-101. PubMed ID: 33774162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
    Ni K; Luo T; Nash GT; Lin W
    Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biogenic nanoparticles as immunomodulator for tumor treatment.
    Cheng K; Kang Q; Zhao X
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Nov; 12(6):e1646. PubMed ID: 32464709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining nanomedicine and immune checkpoint therapy for cancer immunotherapy.
    Boone CE; Wang L; Gautam A; Newton IG; Steinmetz NF
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jan; 14(1):e1739. PubMed ID: 34296535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanical Immunoengineering of T cells for Therapeutic Applications.
    Lei K; Kurum A; Tang L
    Acc Chem Res; 2020 Dec; 53(12):2777-2790. PubMed ID: 33258577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment.
    Gao Q; Feng J; Liu W; Wen C; Wu Y; Liao Q; Zou L; Sui X; Xie T; Zhang J; Hu Y
    Adv Drug Deliv Rev; 2022 Sep; 188():114445. PubMed ID: 35820601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotechnology in the arena of cancer immunotherapy.
    Asadujjaman M; Cho KH; Jang DJ; Kim JE; Jee JP
    Arch Pharm Res; 2020 Jan; 43(1):58-79. PubMed ID: 31956965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomedicine-Combined Immunotherapy for Cancer.
    Huang S; Zhao Q
    Curr Med Chem; 2020; 27(34):5716-5729. PubMed ID: 31250752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Green Synthesis of Gold Nanoparticles Using Plant Extracts as Beneficial Prospect for Cancer Theranostics.
    Bharadwaj KK; Rabha B; Pati S; Sarkar T; Choudhury BK; Barman A; Bhattacharjya D; Srivastava A; Baishya D; Edinur HA; Abdul Kari Z; Mohd Noor NH
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34770796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticle-Based Nanomedicines to Promote Cancer Immunotherapy: Recent Advances and Future Directions.
    Liu J; Zhang R; Xu ZP
    Small; 2019 Aug; 15(32):e1900262. PubMed ID: 30908864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-Targeted Nanomedicine for Immunotherapy.
    Cabral H; Kinoh H; Kataoka K
    Acc Chem Res; 2020 Dec; 53(12):2765-2776. PubMed ID: 33161717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomedicine for Immunotherapy Targeting Hematological Malignancies: Current Approaches and Perspective.
    Allegra A; Gioacchino MD; Tonacci A; Petrarca C; Gangemi S
    Nanomaterials (Basel); 2021 Oct; 11(11):. PubMed ID: 34835555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in engineering local drug delivery systems for cancer immunotherapy.
    Abdou P; Wang Z; Chen Q; Chan A; Zhou DR; Gunadhi V; Gu Z
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Sep; 12(5):e1632. PubMed ID: 32255276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved cancer immunotherapy strategies by nanomedicine.
    Guo S; Feng J; Li Z; Yang S; Qiu X; Xu Y; Shen Z
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(3):e1873. PubMed ID: 36576112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer immunotherapy from biology to nanomedicine.
    Abdelbaky SB; Ibrahim MT; Samy H; Mohamed M; Mohamed H; Mustafa M; Abdelaziz MM; Forrest ML; Khalil IA
    J Control Release; 2021 Aug; 336():410-432. PubMed ID: 34171445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.